{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:23:29Z","timestamp":1787019809103,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP20115"],"award-info":[{"award-number":["GGP20115"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Myoclonus, Epilepsy and Ragged-Red-Fibers (MERRF) is a mitochondrial encephalomyopathy due to heteroplasmic mutations in mitochondrial DNA (mtDNA) most frequently affecting the\n                      <jats:italic>tRNA<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>Lys<\/jats:italic>\n                      <\/jats:sup>\n                      gene at position m.8344A\u2009&gt;\u2009G. Defective tRNA\n                      <jats:sup>Lys<\/jats:sup>\n                      severely impairs mitochondrial protein synthesis and respiratory chain when a high percentage of mutant heteroplasmy crosses the threshold for full-blown clinical phenotype. Therapy is currently limited to symptomatic management of myoclonic epilepsy, and supportive measures to counteract muscle weakness with co-factors\/supplements.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We tested two therapeutic strategies to rescue mitochondrial function in cybrids and fibroblasts carrying different loads of the m.8344A\u2009&gt;\u2009G mutation. The first strategy was aimed at inducing mitochondrial biogenesis directly, over-expressing the master regulator PGC-1\u03b1, or indirectly, through the treatment with nicotinic acid, a NAD\n                      <jats:sup>+<\/jats:sup>\n                      precursor. The second was aimed at stimulating the removal of damaged mitochondria through prolonged rapamycin treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The first approach slightly increased mitochondrial protein expression and respiration in the wild type and intermediate-mutation load cells, but was ineffective in high-mutation load cell lines. This suggests that induction of mitochondrial biogenesis may not be sufficient to rescue mitochondrial dysfunction in MERRF cells with high-mutation load. The second approach, when administered chronically (4\u00a0weeks), induced a slight increase of mitochondrial respiration in fibroblasts with high-mutation load, and a significant improvement in fibroblasts with intermediate-mutation load, rescuing completely the bioenergetics defect. This effect was mediated by increased mitochondrial biogenesis, possibly related to the rapamycin-induced inhibition of the Mechanistic Target of Rapamycin Complex 1 (mTORC1) and the consequent activation of the Transcription Factor EB (TFEB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, our results point to rapamycin-based therapy as a promising therapeutic option for MERRF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-022-00519-z","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T07:03:19Z","timestamp":1659510199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rapamycin rescues mitochondrial dysfunction in cells carrying the m.8344A\u2009&gt;\u2009G mutation in the mitochondrial tRNALys"],"prefix":"10.1186","volume":"28","author":[{"given":"Mariantonietta","family":"Capristo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Del Dotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta Valentina","family":"Tropeano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Caporali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"La Morgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Montopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8959-8832","authenticated-orcid":false,"given":"Alessandra","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"issue":"5","key":"519_CR1","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00415-016-8086-3","volume":"263","author":"J Altmann","year":"2016","unstructured":"Altmann J, B\u00fcchner B, Nadaj-Pakleza A, Sch\u00e4fer J, Jackson S, Lehmann D, et al. Expanded phenotypic spectrum of the m.8344A>G \u201cMERRF\u201d mutation: data from the German mitoNET registry. J Neurol. 2016;263(5):961\u201372.","journal-title":"J Neurol"},{"issue":"Pt 3","key":"519_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1042\/bj3420537","volume":"342","author":"H Antonick\u00e1","year":"1999","unstructured":"Antonick\u00e1 H, Floryk D, Klement P, Stratilov\u00e1 L, Hermansk\u00e1 J, Houstkov\u00e1 H, et al. Defective kinetics of cytochrome c oxidase and alteration of mitochondrial membrane potential in fibroblasts and cytoplasmic hybrid cells with the mutation for myoclonus epilepsy with ragged-red fibres ('MERRF\u2019) at position 8344 nt. Biochem J. 1999;342(Pt 3):537\u201344.","journal-title":"Biochem J"},{"issue":"1","key":"519_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0925-4439(95)00034-2","volume":"1271","author":"G Attardi","year":"1995","unstructured":"Attardi G, Yoneda M, Chomyn A. Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems. Biochim Biophys Acta Mol Basis Dis. 1995;1271(1):241\u20138.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"519_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/hmg\/5.2.197","volume":"5","author":"HACM Bentlage","year":"1996","unstructured":"Bentlage HACM, Attardi G. Relationship of genotype to phenotype in fibroblast-derived transmitochondrial cell lines carrying the 3243 mutation associated with the melas encephalomyopathy: shift towards mutant genotype and role of mtDNA copy number. Hum Mol Genet. 1996;5(2):197\u2013205.","journal-title":"Hum Mol Genet"},{"issue":"Pt 5","key":"519_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/brain\/112.5.1231","volume":"112","author":"SF Berkovic","year":"1989","unstructured":"Berkovic SF, Carpenter S, Evans A, Karpati G, Shoubridge EA, Andermann F, et al. Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain. 1989;112(Pt 5):1231\u201360.","journal-title":"Brain"},{"issue":"6","key":"519_CR6","first-page":"1187","volume":"51","author":"L Boulet","year":"1992","unstructured":"Boulet L, Karpati G, Shoubridge EA. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet. 1992;51(6):1187\u2013200.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"519_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/01913120600820112","volume":"30","author":"O Brantov\u00e1","year":"2006","unstructured":"Brantov\u00e1 O, Tesa\u0159ov\u00e1 M, Hans\u00edkov\u00e1 H, Elleder M, Zeman J, Sl\u00e1dkov\u00e1 J. Ultrastructural changes of mitochondria in the cultivated skin fibroblasts of patients with point mutations in mitochondrial DNA. Ultrastruct Pathol. 2006;30(4):239\u201345.","journal-title":"Ultrastruct Pathol"},{"issue":"8","key":"519_CR8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/11396","volume":"5","author":"M Brini","year":"1999","unstructured":"Brini M, Pinton P, King MP, Davidson M, Schon EA, Rizzuto R. A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nat Med. 1999;5(8):951\u20134.","journal-title":"Nat Med"},{"issue":"3","key":"519_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1042\/EBC20170097","volume":"62","author":"V Carelli","year":"2018","unstructured":"Carelli V, La Morgia C. Clinical syndromes associated with mtDNA mutations: where we stand after 30 years. Essays Biochem. 2018;62(3):235\u201354.","journal-title":"Essays Biochem"},{"issue":"2","key":"519_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bbrc.2006.01.152","volume":"342","author":"D Cassandrini","year":"2006","unstructured":"Cassandrini D, Calevo MG, Tessa A, Manfredi G, Fattori F, Meschini MC, et al. A new method for analysis of mitochondrial DNA point mutations and assess levels of heteroplasmy. Biochem Biophys Res Commun. 2006;342(2):387\u201393.","journal-title":"Biochem Biophys Res Commun"},{"key":"519_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.04.001","author":"R Cerutti","year":"2014","unstructured":"Cerutti R, Pirinen E, Lamperti C, Marchet S, Sauve AA, Li W, et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab. 2014. https:\/\/doi.org\/10.1016\/j.cmet.2014.04.001.","journal-title":"Cell Metab"},{"issue":"4","key":"519_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.cmet.2013.03.003","volume":"17","author":"C Chaveroux","year":"2013","unstructured":"Chaveroux C, Eichner LJ, Dufour CR, Shatnawi A, Khoutorsky A, Bourque G, et al. molecular and genetic crosstalks between mtor and err\u03b1 are key determinants of rapamycin-induced nonalcoholic fatty liver. Cell Metab. 2013;17(4):586\u201398.","journal-title":"Cell Metab"},{"issue":"1","key":"519_CR13","doi-asserted-by":"publisher","first-page":"C176","DOI":"10.1152\/ajpcell.00471.2020","volume":"321","author":"NJ Cheema","year":"2021","unstructured":"Cheema NJ, Cameron JM, Hood DA. Effect of rapamycin on mitochondria and lysosomes in fibroblasts from patients with mtDNA mutations. Am J Physiol Cell Physiol. 2021;321(1):C176\u201386.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"519_CR14","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/301813","volume":"62","author":"A Chomyn","year":"1998","unstructured":"Chomyn A. The myoclonic epilepsy and ragged-red fiber mutation provides new insights into human mitochondrial function and genetics. Am J Hum Genet. 1998;62(4):745\u201351.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"519_CR15","first-page":"2236","volume":"11","author":"A Chomyn","year":"1991","unstructured":"Chomyn A, Meola G, Bresolin N, Lai ST, Scarlato G, Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol. 1991;11(4):2236\u201344.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"519_CR16","first-page":"966","volume":"54","author":"A Chomyn","year":"1994","unstructured":"Chomyn A, Lai ST, Shakeley R, Bresolin N, Scarlato G, Attardi G. Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals\u2013and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am J Hum Genet. 1994;54(6):966\u201374.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"519_CR17","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1038\/s41467-021-26746-2","volume":"12","author":"CY Chung","year":"2021","unstructured":"Chung CY, Singh K, Kotiadis VN, Valdebenito GE, Ahn JH, Topley E, et al. Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation. Nat Commun. 2021;12(1):6409.","journal-title":"Nat Commun"},{"issue":"11","key":"519_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708799","volume":"10","author":"G Civiletto","year":"2018","unstructured":"Civiletto G, Dogan SA, Cerutti R, Fagiolari G, Moggio M, Lamperti C, Beninc\u00e1 C, Viscomi C, Zeviani M. Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis. EMBO Mol Med. 2018;10(11):e8799.","journal-title":"EMBO Mol Med"},{"key":"519_CR19","doi-asserted-by":"publisher","DOI":"10.1042\/BST20210460","author":"S Cogliati","year":"2021","unstructured":"Cogliati S, Cabrera-Alarc\u00f3n JL, Enriquez JA. Regulation and functional role of the electron transport chain supercomplexes. Biochem Soc Trans. 2021. https:\/\/doi.org\/10.1042\/BST20210460.","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"519_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0960-8966(93)90122-Z","volume":"3","author":"M Coquet","year":"1993","unstructured":"Coquet M, Degoul F, Vital A, Malgat M, Mazat JP, Louvet-Giendaj C, et al. MERRF family with 8344 mutation in tRNA (lys). Evidence of a mitochondrial vasculopathy in muscle biopsies. Neuromuscul Disord. 1993;3(5):593\u20137.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"519_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/sj.cdd.4400658","volume":"7","author":"CL Crowley","year":"2000","unstructured":"Crowley CL, Payne CM, Bernstein H, Bernstein C, Roe D. The NAD+ precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate. Cell Death Differ. 2000;7(3):314\u201326.","journal-title":"Cell Death Differ"},{"issue":"7170","key":"519_CR22","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nature06322","volume":"450","author":"JT Cunningham","year":"2007","unstructured":"Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1\u2013PGC-1\u03b1 transcriptional complex. Nature. 2007;450(7170):736\u201340.","journal-title":"Nature"},{"issue":"3","key":"519_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/hmg\/ddt450","volume":"23","author":"Y Dai","year":"2014","unstructured":"Dai Y, Zheng K, Clark J, Swerdlow RH, Pulst SM, Sutton JP, et al. Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation. Hum Mol Genet. 2014;23(3):637\u201347.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"519_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s13311-012-0103-3","volume":"9","author":"M De la Mata","year":"2012","unstructured":"De la Mata M, Garrido-Maraver J, Cot\u00e1n D, Cordero MD, Oropesa-\u00c1vila M, Izquierdo LG, et al. Recovery of MERRF fibroblasts and cybrids pathophysiology by coenzyme Q10. Neurotherapeutics. 2012;9(2):446\u201363.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"519_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng0595-47","volume":"10","author":"JA Enriquez","year":"1995","unstructured":"Enriquez JA, Chomyn A, Attardi G. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination. Nat Genet. 1995;10(1):47\u201355.","journal-title":"Nat Genet"},{"issue":"2","key":"519_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.celrep.2017.12.051","volume":"22","author":"M Fakruddin","year":"2018","unstructured":"Fakruddin M, Wei FY, Suzuki T, Asano K, Kaieda T, Omori A, et al. Defective mitochondrial tRNA taurine modification activates global proteostress and leads to mitochondrial disease. Cell Rep. 2018;22(2):482\u201396.","journal-title":"Cell Rep"},{"issue":"6","key":"519_CR27","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.cmet.2019.08.019","volume":"30","author":"S Forsstr\u00f6m","year":"2019","unstructured":"Forsstr\u00f6m S, Jackson CB, Carroll CJ, Kuronen M, Pirinen E, Pradhan S, et al. Fibroblast growth factor 21 drives dynamics of local and systemic stress responses in mitochondrial myopathy with mtDNA deletions. Cell Metab. 2019;30(6):1040-1054.e7.","journal-title":"Cell Metab"},{"issue":"1","key":"519_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0022-510X(80)90031-3","volume":"47","author":"N Fukuhara","year":"1980","unstructured":"Fukuhara N, Tokiguchi S, Shirakawa K, Tsubaki T. Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci. 1980;47(1):117\u201333.","journal-title":"J Neurol Sci"},{"key":"519_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4939-3040-1_11","volume":"1351","author":"PA Gammage","year":"2016","unstructured":"Gammage PA, Van Haute L, Minczuk M. Engineered mtZFNs for manipulation of human mitochondrial DNA heteroplasmy. Methods Mol Biol. 2016;1351:145\u201362.","journal-title":"Methods Mol Biol"},{"issue":"10","key":"519_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fgene.2019.00435","volume":"14","author":"AP Gureev","year":"2019","unstructured":"Gureev AP, Shaforostova EA, Popov VN. Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways. Front Genet. 2019;14(10):435.","journal-title":"Front Genet"},{"issue":"Pt 3","key":"519_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/brain\/116.3.617","volume":"116","author":"SR Hammans","year":"1993","unstructured":"Hammans SR, Sweeney MG, Brockington M, Lennox GG, Lawton NF, Kennedy CR, et al. The mitochondrial DNA transfer RNA(Lys)A\u2013>G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain. 1993;116(Pt 3):617\u201332.","journal-title":"Brain"},{"issue":"10","key":"519_CR32","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/mt.2015.126","volume":"23","author":"M Hashimoto","year":"2015","unstructured":"Hashimoto M, Bacman SR, Peralta S, Falk MJ, Chomyn A, Chan DC, et al. MitoTALEN: a general approach to reduce mutant mtDNA loads and restore oxidative phosphorylation function in mitochondrial diseases. Mol Ther. 2015;23(10):1592\u20139.","journal-title":"Mol Ther"},{"issue":"3","key":"519_CR33","first-page":"551","volume":"52","author":"E Holme","year":"1993","unstructured":"Holme E, Larsson NG, Oldfors A, Tulinius M, Sahlin P, Stenman G. Multiple symmetric lipomas with high levels of mtDNA with the tRNA(Lys) A\u2013>G(8344) mutation as the only manifestation of disease in a carrier of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet. 1993;52(3):551\u20136.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"519_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1212\/WNL.46.1.219","volume":"46","author":"N Howell","year":"1996","unstructured":"Howell N, Kubacka I, Smith R, Frerman F, Parks JK, Parker WD. Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology. 1996;46(1):219\u201322.","journal-title":"Neurology"},{"issue":"9","key":"519_CR35","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000797","volume":"3","author":"O Ignatenko","year":"2020","unstructured":"Ignatenko O, Nikkanen J, Kononov A, Zamboni N, Ince-Dunn G, Suomalainen A. Mitochondrial spongiotic brain disease: astrocytic stress and harmful rapamycin and ketosis effect. Life Sci Alliance. 2020;3(9): e202000797.","journal-title":"Life Sci Alliance."},{"issue":"4","key":"519_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410440409","volume":"44","author":"M Jaksch","year":"1998","unstructured":"Jaksch M, Klopstock T, Kurlemann G, D\u00f6rner M, Hofmann S, Kleinle S, et al. Progressive myoclonus epilepsy and mitochondrial myopathy associated with mutations in the tRNA(Ser(UCN)) gene. Ann Neurol. 1998;44(4):635\u201340.","journal-title":"Ann Neurol"},{"issue":"2","key":"519_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1042\/bj3180401","volume":"318","author":"AM James","year":"1996","unstructured":"James AM, Wei YH, Pang CY, Murphy MP. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem J. 1996;318(2):401\u20137.","journal-title":"Biochem J"},{"issue":"6165","key":"519_CR38","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1126\/science.1244360","volume":"342","author":"SC Johnson","year":"2013","unstructured":"Johnson SC, Yanos ME, Kayser EB, Quintana A, Sangesland M, Castanza A, et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science. 2013;342(6165):1524\u20138.","journal-title":"Science"},{"key":"519_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201403943","author":"NA Khan","year":"2014","unstructured":"Khan NA, Auranen M, Paetau I, Pirinen E, Euro L, Forsstrom S, et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med. 2014. https:\/\/doi.org\/10.1002\/emmm.201403943.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"519_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cmet.2017.07.007","volume":"26","author":"NA Khan","year":"2017","unstructured":"Khan NA, Nikkanen J, Yatsuga S, Jackson C, Wang L, Pradhan S, et al. mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression. Cell Metab. 2017;26(2):419-428.e5.","journal-title":"Cell Metab"},{"issue":"1","key":"519_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3346\/jkms.2002.17.1.103","volume":"17","author":"DS Kim","year":"2002","unstructured":"Kim DS, Jung DS, Park KH, Kim IJ, Kim CM, Lee WH, et al. Histochemical and molecular genetic study of MELAS and MERRF in korean patients. J Korean Med Sci. 2002;17(1):103\u201312.","journal-title":"J Korean Med Sci"},{"key":"519_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0076-6879(96)64029-4","volume":"264","author":"MP King","year":"1996","unstructured":"King MP, Attardi G. Isolation of human cell lines lacking mitochondrial DNA. Methods Enzymol. 1996;264:304\u201313.","journal-title":"Methods Enzymol"},{"issue":"9","key":"519_CR43","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.3390\/ijms22094558","volume":"22","author":"JH Koh","year":"2021","unstructured":"Koh JH, Kim JY. Role of PGC-1\u03b1 in the mitochondrial NAD+ pool in metabolic diseases. Int J Mol Sci. 2021;22(9):4558.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"519_CR44","first-page":"1201","volume":"51","author":"NG Larsson","year":"1992","unstructured":"Larsson NG, Tulinius MH, Holme E, Oldfors A, Andersen O, Wahlstr\u00f6m J, et al. Segregation and manifestations of the mtDNA tRNA(Lys) A\u2013>G(8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet. 1992;51(6):1201\u201312.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"519_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183\u2013203.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"519_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06898-6","author":"R Mahalakshmi","year":"2021","unstructured":"Mahalakshmi R, Priyanga J, Bhakta-Guha D, Guha G. Hormetic effect of low doses of rapamycin triggers anti-aging cascades in WRL-68 cells by modulating an mTOR-mitochondria cross-talk. Mol Biol Rep. 2021. https:\/\/doi.org\/10.1007\/s11033-021-06898-6.","journal-title":"Mol Biol Rep"},{"issue":"22","key":"519_CR47","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1212\/WNL.0b013e318294b44c","volume":"80","author":"M Mancuso","year":"2013","unstructured":"Mancuso M, Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP, et al. Phenotypic heterogeneity of the 8344A>G mtDNA \u201cMERRF\u201d mutation. Neurology. 2013;80(22):2049\u201354.","journal-title":"Neurology"},{"issue":"1","key":"519_CR48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cmet.2016.11.003","volume":"25","author":"G Mansueto","year":"2017","unstructured":"Mansueto G, Armani A, Viscomi C, D\u2019Orsi L, Cegli RD, Polishchuk EV, et al. Transcription Factor EB Controls Metabolic Flexibility during Exercise. Cell Metab. 2017;25(1):182\u201396.","journal-title":"Cell Metab"},{"issue":"11","key":"519_CR49","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1093\/hmg\/ddaa014","volume":"29","author":"A Maresca","year":"2020","unstructured":"Maresca A, Del Dotto V, Capristo M, Scimonelli E, Tagliavini F, Morandi L, et al. DNMT1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism. Hum Mol Genet. 2020;29(11):1864\u201381.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"519_CR50","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00109-020-01967-y","volume":"98","author":"A Maresca","year":"2020","unstructured":"Maresca A, Del Dotto V, Romagnoli M, La Morgia C, Di Vito L, Capristo M, et al. Expanding and validating the biomarkers for mitochondrial diseases. J Mol Med. 2020;98(10):1467\u201378.","journal-title":"J Mol Med"},{"issue":"6","key":"519_CR51","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4161\/auto.19653","volume":"8","author":"JA Martina","year":"2012","unstructured":"Martina JA, Chen Y, Gucek M, Puertollano R. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy. 2012;8(6):903\u201314.","journal-title":"Autophagy"},{"issue":"6","key":"519_CR52","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.braindev.2012.08.006","volume":"35","author":"Y Monden","year":"2013","unstructured":"Monden Y, Mori M, Kuwajima M, Goto T, Yamagata T, Momoi MY. Late-onset Leigh syndrome with myoclonic epilepsy with ragged-red fibers. Brain Dev. 2013;35(6):582\u20135.","journal-title":"Brain Dev"},{"issue":"5","key":"519_CR53","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","volume":"18","author":"M Morita","year":"2013","unstructured":"Morita M, Gravel SP, Ch\u00e9nard V, Sikstr\u00f6m K, Zheng L, Alain T, et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab. 2013;18(5):698\u2013711.","journal-title":"Cell Metab"},{"issue":"4","key":"519_CR54","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4161\/15384101.2014.991572","volume":"14","author":"M Morita","year":"2015","unstructured":"Morita M, Gravel SP, Hulea L, Larsson O, Pollak M, St-Pierre J, et al. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle. 2015;14(4):473\u201380.","journal-title":"Cell Cycle"},{"issue":"3","key":"519_CR55","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8","volume":"20","author":"M Ozawa","year":"1997","unstructured":"Ozawa M, Nishino I, Horai S, Nonaka I, Goto YI. Myoclonus epilepsy associated with ragged-red fibers: a G-to-A mutation at nucleotide pair 8363 in mitochondrial tRNA(Lys) in two families. Muscle Nerve. 1997;20(3):271\u20138.","journal-title":"Muscle Nerve"},{"issue":"5","key":"519_CR56","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/hmg\/ddv619","volume":"25","author":"E Perli","year":"2016","unstructured":"Perli E, Fiorillo A, Giordano C, Pisano A, Montanari A, Grazioli P, et al. Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutations. Hum Mol Genet. 2016;25(5):903\u201315.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"519_CR57","doi-asserted-by":"publisher","first-page":"7675","DOI":"10.1096\/fj.201903270R","volume":"34","author":"E Perli","year":"2020","unstructured":"Perli E, Pisano A, Pignataro MG, Campese AF, Pelullo M, Genovese I, et al. Exogenous peptides are able to penetrate human cell and mitochondrial membranes, stabilize mitochondrial tRNA structures, and rescue severe mitochondrial defects. FASEB J. 2020;34(6):7675\u201386.","journal-title":"FASEB J"},{"issue":"6","key":"519_CR58","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cmet.2020.04.008","volume":"31","author":"E Pirinen","year":"2020","unstructured":"Pirinen E, Auranen M, Khan NA, Brilhante V, Urho N, Pessia A, et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metab. 2020;31(6):1078-1090.e5.","journal-title":"Cell Metab"},{"issue":"1","key":"519_CR59","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1038\/s41467-018-06471-z","volume":"9","author":"U Richter","year":"2018","unstructured":"Richter U, Evans ME, Clark WC, Marttinen P, Shoubridge EA, Suomalainen A, et al. RNA modification landscape of the human mitochondrial tRNALys regulates protein synthesis. Nat Commun. 2018;9(1):3966.","journal-title":"Nat Commun"},{"issue":"8","key":"519_CR60","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/1873-3468.14049","volume":"595","author":"U Richter","year":"2021","unstructured":"Richter U, McFarland R, Taylor RW, Pickett SJ. The molecular pathology of pathogenic mitochondrial tRNA variants. FEBS Lett. 2021;595(8):1003\u201324.","journal-title":"FEBS Lett"},{"issue":"2","key":"519_CR61","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mus.20688","volume":"35","author":"MC Rodriguez","year":"2007","unstructured":"Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve. 2007;35(2):235\u201342.","journal-title":"Muscle Nerve"},{"issue":"5","key":"519_CR62","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","volume":"31","author":"C Settembre","year":"2012","unstructured":"Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012;31(5):1095\u2013108.","journal-title":"EMBO J"},{"issue":"6","key":"519_CR63","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ncb2718","volume":"15","author":"C Settembre","year":"2013","unstructured":"Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O, et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol. 2013;15(6):647\u201358.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"519_CR64","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1474-4422(05)70043-0","volume":"4","author":"A Shahwan","year":"2005","unstructured":"Shahwan A, Farrell M, Delanty N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol. 2005;4(4):239\u201348.","journal-title":"Lancet Neurol"},{"issue":"6","key":"519_CR65","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0092-8674(90)90059-N","volume":"61","author":"JM Shoffner","year":"1990","unstructured":"Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell. 1990;61(6):931\u20137.","journal-title":"Cell"},{"issue":"6","key":"519_CR66","first-page":"1213","volume":"51","author":"G Silvestri","year":"1992","unstructured":"Silvestri G, Moraes CT, Shanske S, Oh SJ, DiMauro S. A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet. 1992;51(6):1213\u20137.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"519_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrm.2017.66","volume":"19","author":"A Suomalainen","year":"2018","unstructured":"Suomalainen A, Battersby BJ. Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol. 2018;19(2):77\u201392.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"519_CR68","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/hmg\/4.8.1421","volume":"4","author":"V Tiranti","year":"1995","unstructured":"Tiranti V, Chariot P, Carella F, Toscano A, Soliveri P, Girlanda P, et al. Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet. 1995;4(8):1421\u20137.","journal-title":"Hum Mol Genet"},{"key":"519_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13046","author":"C Viscomi","year":"2020","unstructured":"Viscomi C, Zeviani M. Strategies for fighting mitochondrial diseases\u2014Viscomi\u20142020. J Intern Med. 2020. https:\/\/doi.org\/10.1111\/joim.13046.","journal-title":"J Intern Med"},{"issue":"4","key":"519_CR70","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/0092-8674(88)90218-8","volume":"55","author":"DC Wallace","year":"1988","unstructured":"Wallace DC, Zheng XX, Lott MT, Shoffner JM, Hodge JA, Kelley RI, et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell. 1988;55(4):601\u201310.","journal-title":"Cell"},{"issue":"49","key":"519_CR71","doi-asserted-by":"publisher","first-page":"80131","DOI":"10.18632\/oncotarget.12560","volume":"7","author":"A Wang","year":"2016","unstructured":"Wang A, Mouser J, Pitt J, Promislow D, Kaeberlein M. Rapamycin enhances survival in a Drosophila model of mitochondrial disease. Oncotarget. 2016;7(49):80131\u20139.","journal-title":"Oncotarget"},{"key":"519_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110272","volume":"128","author":"S Wang","year":"2020","unstructured":"Wang S, Chen Y, Li X, Zhang W, Liu Z, Wu M, et al. Emerging role of transcription factor EB in mitochondrial quality control. Biomed Pharmacother. 2020;128: 110272.","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"519_CR73","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1093\/emboj\/20.17.4794","volume":"20","author":"T Yasukawa","year":"2001","unstructured":"Yasukawa T, Suzuki T, Ishii N, Ohta S, Watanabe K. Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease. EMBO J. 2001;20(17):4794\u2013802.","journal-title":"EMBO J"},{"issue":"5","key":"519_CR74","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.13378","volume":"23","author":"X Zheng","year":"2016","unstructured":"Zheng X, Boyer L, Jin M, Kim Y, Fan W, Bardy C, et al. Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration. Elife. 2016;23(5): e13378.","journal-title":"Elife"},{"issue":"20","key":"519_CR75","doi-asserted-by":"publisher","first-page":"7746","DOI":"10.1523\/JNEUROSCI.17-20-07746.1997","volume":"17","author":"L Zhou","year":"1997","unstructured":"Zhou L, Chomyn A, Attardi G, Miller CA. Myoclonic epilepsy and ragged red fibers (MERRF) syndrome: selective vulnerability of CNS neurons does not correlate with the level of mitochondrial tRNAlys mutation in individual neuronal isolates. J Neurosci. 1997;17(20):7746\u201353.","journal-title":"J Neurosci"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00519-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-022-00519-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00519-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T08:07:02Z","timestamp":1659514022000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-022-00519-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1186\/s10020-022-00519-z","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures on patients were conducted according to the Declaration of Helsinki and after having obtained the approval of the institutional ethical board (Comitato Etico Interaziendale Bologna-Imola, study CE-BI 13036). Informed written consent for study participation have been obtained from patients and volunteers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}